BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12226745)

  • 1. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
    Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L
    Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.
    Marchetti S; Gimond C; Roux D; Gothié E; Pouysségur J; Pagès G
    J Cell Physiol; 2004 Jun; 199(3):441-50. PubMed ID: 15095291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
    Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
    Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
    J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
    Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
    J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling.
    Nkabyo YS; Go YM; Ziegler TR; Jones DP
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G70-8. PubMed ID: 15746213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyrotropin receptor is not involved in the activation of p42/p44 mitogen-activated protein kinases by thyrotropin preparations in Chinese hamster ovary cells expressing the human thyrotropin receptor.
    Corrèze C; Blondeau JP; Pomerance M
    Thyroid; 2000 Sep; 10(9):747-52. PubMed ID: 11041451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormones regulate DNA-synthesis and cell-cycle proteins by activation of PKCalpha and p42/44 MAPK in chick embryo hepatocytes.
    Alisi A; Spagnuolo S; Napoletano S; Spaziani A; Leoni S
    J Cell Physiol; 2004 Nov; 201(2):259-65. PubMed ID: 15334660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
    Lin WN; Luo SF; Lee CW; Wang CC; Wang JS; Yang CM
    Cell Signal; 2007 Jun; 19(6):1258-67. PubMed ID: 17303384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
    Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
    Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
    Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells.
    Lin FS; Lin CC; Chien CS; Luo SF; Yang CM
    J Cell Physiol; 2005 Feb; 202(2):464-73. PubMed ID: 15389584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes.
    Hsieh HL; Wang HH; Wu CY; Jou MJ; Yen MH; Parker P; Yang CM
    Cell Signal; 2007 Feb; 19(2):330-40. PubMed ID: 16935468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.
    Chang YT; Gray NS; Rosania GR; Sutherlin DP; Kwon S; Norman TC; Sarohia R; Leost M; Meijer L; Schultz PG
    Chem Biol; 1999 Jun; 6(6):361-75. PubMed ID: 10375538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ; Dickenson JM
    Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Ras in ethanol modulation of angiotensin II activated p42/p44 MAP kinase in rat hepatocytes.
    Park PH; Aroor AR; Shukla SD
    Life Sci; 2006 Nov; 79(25):2357-63. PubMed ID: 16950409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
    Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
    Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.